端粒、端粒酶与妇科恶性肿瘤早期诊断及肿瘤恶变预测被引量：2

导出

摘要端粒是染色体末端独特的蛋白质—DNA结构,具有保护染色体作用。端粒酶是由RNA和蛋白质亚基组成的一种特殊反转录酶,能延长端粒。对许多系统内端粒酶的检测结果表明:在肿瘤组织内通常表达,而在对照正常组织内几乎不表达。端粒酶活性与肿瘤发生发展密切相关,可作为肿瘤的诊断和判断预后的指标。

作者黎华文李英勇

机构地区广东医学院附属医院妇产科

出处《国外医学（妇产科学分册）》 2002年第3期175-177,共3页 Foreign Medical Sciences(Obstet Gynecol Fascicle)

关键词早期诊断恶变预测端粒端粒酶妇科肿瘤

参考文献20

1Kim NW,Piatyszek MA,Prowse KR,et al.Specific association of human telomerase activity with immortal cells and cancer.Science,1994,266(23):2011-2015
2Hahn WC,Meyerson M.Telomerase activation,cellular immortalization and cancer.Ann Med,2001,33(2):123-129
3Nakamura TM,Cech TR.Reversing time:origin of telomerase.Cell,1998,92(5):587-590
4Feng J,Funk WD,Wang SS,et al.The RNA component of telomerase.Science,1995,269:1236-1241
5Kyo S,Kanaya T,Takakura M,et al.Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues.Int J Cancer,1999,80(1):60-63
6Nakayama J,Saito M,Nakamura H,et al.TCLL:A gene encoding aprotein component of mammalian telomerase is novel member of WD repeats family.Cell,1997,88:857-884
7Frost M,Bobak JB,Gianani R,et al.Localization of telomerase hTERT protein and hTR in benign mucosa,dysplasia,and squamous cell carcinoma of cervix.Am J Clin Pathol,2000,114(5):726-734
8Oshita T,Nagai N,Ohama K.Expression of telomerase reverse transcriptase mRNA and its quantitative analysis in human endometrial cancer.Int J Oncot,2000,17(6):1225-1230
9Kyo S,Kanaya T,Takaura M,et al.Expression of human telomerase subunits in ovarian malignant,borderline and benign tumous.Int J Cancer,1999,80(6):804-809
10Kyo S,Takaura M,Tanaka M,et al.Telomerase activity in cervical cancer is quantitatively distinct from that in its precursor lesions.Int J Cancer,1998,790):66-70

1Wang J;Xie LY;Allan S.Myc activates telomerase,1998(01).
2Hart KW;Williams OM;Thelwell N.Novel method for detection typing and quantification of human papillomaviruses in clinical samples[J],2001(09).
3Nagai N;Oshita T;Murakami J.Semiquantitative analysis of telomerase activity in cervical cancer and precancerous lesions,1999(02).
4Frost M;Bobak JB;Gianani R.Localization of telomerase hTERT protein and hTR in benigh mucosa dysplasia and squamous cell carcinoma of cervix[J],2000(05).
5Wolf JK;Ramirez PT.The molecular biology of cervical cancer[J],2001(06).
6Mantovani F;Banks L.Inhibition of E6 induced degradation of p53 is not sufficient for stablilization of p53 protein in cervical tumour derived cell lines[J],1999(22).
7Brehm A;Nielsen SJ;Miska EA.The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth[J],1999(09).
8Milde - Langosch K;Riethdorf S;Loning T.Association of human papillomavirus infection with carcinoma of the cervix uteri and its precursor lesions:theoretical and practical implications,2000.
9Zhang BY;Spandau DF;Roman A.E5 ptotein of human papillomavirus type 16 protects human foreskin deratinocytes from UVB - irradiation on - induced apoptosis[J],2002.
10Mitsuo Yoshinouchi;Atsushi Hongo;Keichiro Nakamura.Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers[J],1999(11).

国外医学（妇产科学分册）

2002年第3期

内容加载中请稍等...